Aoxing Pharmaceutical Company AOXG Stock
Aoxing Pharmaceutical Company Price Chart
Aoxing Pharmaceutical Company AOXG Financial and Trading Overview
Aoxing Pharmaceutical Company stock price | 0.0080 USD |
Previous Close | 0.001 USD |
Open | 0.001 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 0.001 - 0.001 USD |
52 Week Range | 0.0001 - 0.004 USD |
Volume | 308 USD |
Avg. Volume | 10.94K USD |
Market Cap | 1.43M USD |
Beta (5Y Monthly) | -53.51232 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
AOXG Valuation Measures
Enterprise Value | 19.7M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.0475906 |
Price/Book (mrq) | 0.0039840643 |
Enterprise Value/Revenue | 0.654 |
Enterprise Value/EBITDA | 10.082 |
Trading Information
Aoxing Pharmaceutical Company Stock Price History
Beta (5Y Monthly) | -53.51232 |
52-Week Change | -37.50% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.004 USD |
52 Week Low | 0.0001 USD |
50-Day Moving Average | 0.0013 USD |
200-Day Moving Average | 0.001062 USD |
AOXG Share Statistics
Avg. Volume (3 month) | 10.94K USD |
Avg. Daily Volume (10-Days) | 119 USD |
Shares Outstanding | 76.21M |
Float | 46.19M |
Short Ratio | 0.03 |
% Held by Insiders | 0% |
% Held by Institutions | 0% |
Shares Short | 13.24K |
Short % of Float | 0.029% |
Short % of Shares Outstanding | 0.020% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:2 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | June 30, 2016 |
Most Recent Quarter (mrq) | March 31, 2017 |
Next Fiscal Year End | June 30, 2017 |
Profitability
Profit Margin | -4.86% |
Operating Margin (ttm) | 3.21% |
Gross Margin | 76.18% |
EBITDA Margin | 6.48% |
Management Effectiveness
Return on Assets (ttm) | 0.99% |
Return on Equity (ttm) | -7.56% |
Income Statement
Revenue (ttm) | 30.11M USD |
Revenue Per Share (ttm) | 0.4 USD |
Quarterly Revenue Growth (yoy) | -13.10% |
Gross Profit (ttm) | 24.55M USD |
EBITDA | 1.95M USD |
Net Income Avi to Common (ttm) | -1463304 USD |
Diluted EPS (ttm) | 0 |
Quarterly Earnings Growth (yoy) | -78.79% |
Balance Sheet
Total Cash (mrq) | 7.08M USD |
Total Cash Per Share (mrq) | 0.09 USD |
Total Debt (mrq) | 27.72M USD |
Total Debt/Equity (mrq) | 153.29 USD |
Current Ratio (mrq) | 0.792 |
Book Value Per Share (mrq) | 0.251 |
Cash Flow Statement
Operating Cash Flow (ttm) | -1363572 USD |
Levered Free Cash Flow (ttm) | 264.82K USD |
Profile of Aoxing Pharmaceutical Company
Country | United States |
State | N/A |
City | Shijiazhuang |
Address | No. 2 Bojin Mansion |
ZIP | N/A |
Phone | 86 311 8961 8579 |
Website | https://axzyen.icm.cn |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 346 |
Aoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People's Republic of China. The company's principal products include Zhongtong'an, a capsule of herbal extraction for the indication of oral and dental pain; and Yiqi Qiangshen Granule, an OTC herbal extraction for tonifying qi and empowering body, and promoting blood circulation to remove meridian obstruction, as well as Tilidine hydrochloride, an orally-absorbed synthetic narcotic analgesic tablet used in 50mg or 100mg dosage for relief of acute, moderate to severe pain, and chronic cancer-related pain. Its products under development comprise Oxycodone and Acetaminophen tablets and capsules, which has completed clinical trials for the treatment of acute and chronic pain; Buprenorphine/Naloxone, a sublingual combo tablet that has completed Phase II clinical trials for the treatment of opioid dependence; and Tilidine/Naloxone, a compound capsule which is in Phase II clinical trial to treat acute and chronic pain. The company was formerly known as China Aoxing Pharmaceutical Company, Inc. and changed its name to Aoxing Pharmaceutical Company, Inc. in March 2010. Aoxing Pharmaceutical Company, Inc. is headquartered in Shijiazhuang, China.
Q&A For Aoxing Pharmaceutical Company Stock
What is a current AOXG stock price?
Aoxing Pharmaceutical Company AOXG stock price today per share is 0.0080 USD.
How to purchase Aoxing Pharmaceutical Company stock?
You can buy AOXG shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Aoxing Pharmaceutical Company?
The stock symbol or ticker of Aoxing Pharmaceutical Company is AOXG.
Which industry does the Aoxing Pharmaceutical Company company belong to?
The Aoxing Pharmaceutical Company industry is Drug Manufacturers-Specialty & Generic.
How many shares does Aoxing Pharmaceutical Company have in circulation?
The max supply of Aoxing Pharmaceutical Company shares is 381.21M.
What is Aoxing Pharmaceutical Company Price to Earnings Ratio (PE Ratio)?
Aoxing Pharmaceutical Company PE Ratio is now.
What was Aoxing Pharmaceutical Company earnings per share over the trailing 12 months (TTM)?
Aoxing Pharmaceutical Company EPS is 0 USD over the trailing 12 months.
Which sector does the Aoxing Pharmaceutical Company company belong to?
The Aoxing Pharmaceutical Company sector is Healthcare.